Molecular Similarity Characterization Using CoMFA

Perspectives in Drug Discovery and Design

Volumn 12, Issue , 1998, Pages 215-231

  Langer, Thierry ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0004945561     PISSN: 09282866     EISSN: None     Source Type: Journal    
DOI: 10.1023/a:1017002626602     Document Type: Article

References (33)

1. Rouvray, D.H., The evolution of the concept of molecular similarity, In Johnson, M.A. and Maggiora, G.M. (Eds.) Concepts and applications of molecular similarity, John Wiley, Inc. New York, 1990, pp. 15-42.
2. Dean, P.M., Defining molecular similarity and complementary for drug design, In Dean, P.M. (Ed.) Molecular similarity in drug design, Blackie Academic and Professional, London, U.K., 1995, pp. 1-23.
3. Dean, P.M., Molecular similarity, In Kubinyi, H. (Ed.) 3D QSAR in Drug design: Theory, Methods and Applications, ESCOM, Leiden, The Netherlands, 1993, pp. 150-172.
4. Carbó, R., Leyda, L. and Arnau, M., An electron density measure of the similarity between two compounds, Int. J. Quantum Chem., 17 (1980) 1185-1189.
5. Hodgkin, E.E. and Richards, W.G., Molecular similarity based on electrostatic potential and electric field, Int. J. Quantum Chem. Quantum Biol. Symp., 14 (1987) 105-110.
6. Leach, A.R., The treatment of conformationally flexible molecules in similarity and complementarity searching, In Dean, P.M. (Ed.) Molecular similarity in drug design, Blackie Academic & Professional, London, U.K., 1995, pp. 57-88.
7. Rozas, I., Du, Q. and Arteca, G.A., Interrelation between electrostatic and lipophilicity potentials on molecular surfaces, J. Mol. Graph., 13 (1995) 98-108.
8. Burgess, E.M., Ruell, J.A., Zalkow, L.H. and Haugwitz, R.D., Molecular similarity from atomic electrostatic multipole comparisons: Application to anti-HIV drugs, J. Med. Chem., 38 (1995) 1635-1640.
9. Benigni, R., Cotta-Ramusino, M., Giorgi, F. and Gallo, G., Molecular similarity matrices and quantitative structure-activity relationships: A case study with methodological implications, J. Med. Chem., 38 (1995) 629-635.
10. Briem, H. and Kuntz, I.D., Molecular similarity based on DOCK-generated fingerprints, J. Med. Chem., 39 (1996) 3401-3408.
11. Montanari, C.A., Tute, M.S., Beezer, A.E. and Mitchell, J.C., Determination of receptor-bound drug conformations by QSAR using flexible fitting to derive a molecular similarity index, J. Comput.-Aided Mol. Design, 10 (1996) 67-73.
12. Jain, A.N., Koile, K. and Chapman, D., Compass: Predicting biological activities from molecular surface properties - performance comparisons on a steroid benchmark, J. Med. Chem., 37 (1994) 2325-2327.
13. Cramer III, R.D., Patterson, D.E. and Bunce, J.D., Comparative molecular field analysis (CoMFA): 1. Effect of shape on binding of steroids to carrier proteins, J. Am. Chem. Soc., 110 (1988) 5959-5967.
14. Lin, T.C., Pavlik, P.A. and Martin, Y.C., Use of molecular fields to compare series of potentially bioactive molecules designed by scientists or by computer, Tetrahedron Comput. Methodol., 3 (1990) 723-738.
15. Clementi, S., Cruciani, G., Baroni, M. and Costantino, G., Series design, In Kubinyi, H. (Ed.) 3D QSAR in drug design: Theory, methods and applications, ESCOM, Leiden, The Netherlands, 1993, pp. 567-582.
16. Wold, S., Sjöström, M., Carlson, R., Lundstedt, T., Hellberg, S., Skagerberg, B., Wirkström, C. and Öhman, J., Multivariate design, Anal. Chim. Acta., 191 (1986) 17-32.
17. Van de Waterbeemd, H., Clementi, S., Costantino, G., Carrupt, P.-A. and Testa, B., CoMFA derived substituent descriptors for structure-property correlations, In Kubinyi, H. (Ed.) 3D QSAR in drug design: Theory, methods, and applications, ESCOM, Leiden, The Netherlands, 1993, pp. 697-707.
18. Clementi, S., Cruciani, G., Riganelli, D., Valigi, R., Costantino, G., Baroni, M. and Wold, S., Autocorrelation as a tool for a congruent description of molecules in 3D QSAR studies, Pharm. Pharmacol. Lett., 3 (1993) 433-438.
19. Hellberg, S., Sjöström, M., Skagerberg, B. and Wold, S., Peptide quantitative structure-activity relationships: A multivariate approach, J. Med. Chem., 30 (1987) 1127-1135.
20. Norinder, U., Theoretical amino acid descriptors: Application to bradykinin potentiating peptides, Peptides, 12 (1991) 1223-1227.
21. Cocchi, M. and Johansson, E., Amino acids characterization by GRID and multivariate data analysis, Quant. Struct.-Act. Relat., 12 (1993) 1-8.
22. Goodford, P., A computational procedure for determining energetically favourable binding sites an biologically important macromolecules, J. Med. Chem., 28 (1985) 849-857.
23. Hellberg, S., Sjöström, M., Skagerberg, B. and Wold, S., On the use of multipositionally varied test series for quantitative structure-activity relationships, Acta Pharm. Jugosl., 37 (1987) 53-65.
24. Langer, T., Molecular similarity determination of heteroaromatics using CoMFA and multivariate data analysis, Quant. Struct.-Act. Relat., 13 (1994) 402-405.
25. Langer, T., Molecular similarity determination of heteroaromatic ring fragments using GRID and multivariate data analysis, Quant. Struct.-Act. Relat., 15 (1996) 469-474.
26. Clark, M., Cramer III, R.D. and Van Opdenbosch, N., Validation of the general purpose Tripos 5.2 force field, J. Comput. Chem., 10 (1989) 982-1012.
27. Wermuth, C.G., Molecular variations based on isosteric replacements, In Wermuth, C.G. (Ed.) The practice of medicinal chemistry, Academic Press, London, U.K. 1996, pp. 203-237.
28. Caruso, L., Katritzky, A.R. and Musumarra, G., Classical and magnetic aromaticities as new descriptors for heteroaromatics in QSAR: 3. Principal properties for heteroaromatics, Quant. Struct.-Act. Relat., 12 (1993) 146-151.
29. SYBYL, Versions 6.01, 6.03, 6.2, Tripos Associates, St. Louis, MO, U.S.A.
30. Saari, W.S., Wai, J.S., Fisher, T.E., Thomas, C.M., Hoffman, J.M., Rooney, C.S., Smith. A.M., Jones, J.H., Bamberger, D.L., Goldman, M.E., O'Brien, J.A., Nunberg, J.H., Quintero, J.C., Schleif, W.A., Emini, E.A. and Anderson, P.S., Synthesis and evaluation of 2-pyridinone derivatives as HIV-1-specific reverse transcriptase inhibitors, J. Med. Chem., 35 ( 1992) 3792-3802.
31. Clementi, S., Cruciani, G., Fifi, P., Riganelli, D., Valigi, R. and Musumarra, G., A new set of principal properties for heteroaromatics obtained by GRID, Quant. Struc.-Act. Relat., 15 (1996) 108-120.
32. Gibson, S., McGuire, R. and Rees, D.C., Principal components describing biological activities and molecular diversity of heterocyclic aromatic ring fragments, J. Med. Chem., 39 (1996) 4065-4072.
33. Van de Waterbeemd, H., Carrupt, P.-A., Testa, B. and Kier, L.B., Multivariate data modeling of new steric, topological and CoMFA-derived substituent parameters, In Wermuth, C.G. (Ed.) Trends in QSAR and Molecular Modelling 92, ESCOM, Leiden, The Netherlands, 1993, pp. 69-75.